SCHEMBL18180481

SCHEMBL18180481

Cc1ccc(S(=O)(=O)Oc2cc(Cc3ccccc3)on2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
P2RY12 Q9H244 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
CA12 O43570 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
ATM Q13315 1/20 0.40
CA9 Q16790 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
CYP2C19 P33261 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.38
MCHR1 Q99705 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18180493 0.88 P2RY12 (0.39) KEAP1NFE2L2P2RY12CA12CYP1A2
SCHEMBL18180216 0.88 KMT2A (0.40) KEAP1NFE2L2P2RY12BCHEACHE
SCHEMBL18180198 0.79 CYP11B1 (0.52) CYP11B1CYP11B2ALDH1A1
SCHEMBL14367311 0.78 NPC1 (0.41) CYP3A4L3MBTL1MEN1MAPTKMT2A
SCHEMBL1714565 0.75 SMN1; SMN2 (0.41) CA12CYP1A2CYP3A4MEN1MAPT
SCHEMBL1715299 0.75 TSHR (0.44) CYP1A2L3MBTL1MEN1MAPTKMT2A
SCHEMBL11373381 0.73 SMN1; SMN2 (0.40) KEAP1NFE2L2CYP1A2CYP3A4MEN1
SCHEMBL27618647 0.73 SMN1; SMN2 (0.40) CA12CYP1A2CYP3A4MEN1MAPT
SCHEMBL15455882 0.72 AR (0.40) KEAP1NFE2L2CA12CYP1A2CYP3A4
SCHEMBL11364194 0.71 NPC1 (0.38) KEAP1NFE2L2CYP1A2CYP3A4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016169514-A1 IMIDAZOLE COMPOUND 广东众生药业股份有限公司 2016-10-27 WO disclosed